Back

SOCS1 expression in prostate epithelial cells is essential for tissue homeostasis and tumor suppression

Ihsan, A. U.; Namvarpour, M.; Moradzad, M.; Armas Cayarga, A.; Lim, E. N. K.; Binoy Joseph, D.; Petkiewicz, S.; Masse, E.; Yoshimura, A.; Ferbeyre, G.; Menendez, A.; Ramanathan, S.; Ilangumaran, S.

2026-05-13 cancer biology
10.64898/2026.05.09.723770 bioRxiv
Show abstract

Suppressor of cytokine signaling 1 (SOCS1) negative regulates inflammatory cytokine production and attenuates oncogenic growth factor signaling pathways. Reduced SOCS1 protein expression in human prostate cancer correlates with greater disease severity. To define the physiological functions of SOCS1 functions in the prostate, we conditionally ablated Socs1 in prostate epithelial cells of C57BL/6 mice. These Socs1{Delta}PE mice exhibited normal prostate development, maturation and lobular architecture. However, adult Socs1{Delta}PEmice developed progressive epithelial hyperplasia and inflammatory cell infiltration that were temporally and spatially distinct. SOCS1-deficient prostate showed increased epithelial cell proliferation and elevated oxidative stress markers, and prostate organoids recapitulated this hyperplasia phenotype. Diet-induced obesity exacerbated both hyperplasia and inflammation in SOCS1-deficient prostate. Upon transurethral infection with uropathogenic Escherichia coli UPEC1677 expressing the genotoxin colibactin, Socs1{Delta}PE mice developed invasive prostate cancer with complete loss of lobular architecture, whereas control mice developed hyperplasia and pre-neoplastic lesions. In vitro, SOCS1-deficient prostate organoid-derived epithelial cells exhibited increased DNA damage following exposure to UPEC1677. Deletion of the colibactin biosynthetic gene clbP in UPEC1677 abolished its ability to induce DNA damage in SOCS1-deficient cells and to drive prostate cancer in vivo. Proteomic analysis of prostate organoids revealed dysregulation of basal and luminal epithelial lineage markers and signaling pathway proteins that could promote neoplasia in SOCS1-deficient cells. Collectively, these findings establish an essential, epithelial cell-intrinsic role for SOCS1 in maintaining prostate tissue homeostasis by restraining proliferation, regulating lineage plasticity, limiting inflammation and oxidative stress, and conferring protection against genotoxic injury and neoplastic transformation.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
JCI Insight
241 papers in training set
Top 0.1%
14.5%
2
Cell Reports
1338 papers in training set
Top 2%
10.2%
3
Nature Communications
4913 papers in training set
Top 23%
8.3%
4
Journal of Clinical Investigation
164 papers in training set
Top 0.2%
6.9%
5
eLife
5422 papers in training set
Top 16%
4.9%
6
Oncogene
76 papers in training set
Top 0.3%
4.9%
7
Cancer Research
116 papers in training set
Top 0.4%
4.9%
50% of probability mass above
8
Molecular Cancer Research
42 papers in training set
Top 0.1%
4.4%
9
Cell Death & Disease
126 papers in training set
Top 0.5%
2.5%
10
The Prostate
11 papers in training set
Top 0.1%
2.4%
11
Clinical Cancer Research
58 papers in training set
Top 0.8%
2.1%
12
Cancer Research Communications
46 papers in training set
Top 0.4%
1.7%
13
Molecular Cancer Therapeutics
33 papers in training set
Top 0.3%
1.7%
14
Scientific Reports
3102 papers in training set
Top 58%
1.7%
15
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.4%
1.3%
16
PLOS ONE
4510 papers in training set
Top 61%
1.1%
17
Science Advances
1098 papers in training set
Top 25%
1.0%
18
Genome Medicine
154 papers in training set
Top 6%
1.0%
19
Journal of Biological Chemistry
641 papers in training set
Top 3%
0.9%
20
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.8%
21
Oncogenesis
12 papers in training set
Top 0.2%
0.8%
22
Gastroenterology
40 papers in training set
Top 2%
0.7%
23
British Journal of Cancer
42 papers in training set
Top 2%
0.7%
24
Cell Reports Medicine
140 papers in training set
Top 9%
0.7%
25
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 47%
0.7%
26
PLOS Genetics
756 papers in training set
Top 17%
0.7%
27
Advanced Science
249 papers in training set
Top 23%
0.5%
28
Clinical Epigenetics
53 papers in training set
Top 1%
0.5%
29
Cancers
200 papers in training set
Top 6%
0.5%
30
Cancer Discovery
61 papers in training set
Top 2%
0.5%